Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
    3.
    发明授权
    Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites 失效
    双环碳水化合物作为抗原生物活性物质用于治疗由寄生虫引起的感染

    公开(公告)号:US07125854B2

    公开(公告)日:2006-10-24

    申请号:US10752792

    申请日:2004-01-07

    CPC分类号: C07D493/04

    摘要: The use of bicyclic carbohydrates for the treatment of parasite infections is described. Different bicyclic carbohydrates have been tested in vitro against a number of protozoa. These compounds also have been screened against viruses, tumors, bacteria and fungi. Compound A1, a thiophenyl-containing bicyclic carbohydrate possessed significant activity against Trypanosoma brucei rhodiense, a parasite that causes the lethal sleeping sickness. Compound A2 and Compound A3, bicyclic carbohydrates with halogen containing aryl groups, possessed significant activity against Leishmania donovani, a parasite that causes leishmaniasis. Bicyclic carbohydrates in general, and Compound A1, Compound A2 and Compound A3 more specifically, could be possible treatments for the sleeping sickness and leishmaniasis in the future.

    摘要翻译: 描述了使用双环碳水化合物治疗寄生虫感染。 已经在体外对许多原生动物测试了不同的双环碳水化合物。 这些化合物也已经针对病毒,肿瘤,细菌和真菌进行了筛选。 化合物A1,含噻吩基的双环碳水化合物对引起致死性昏睡病的寄生虫Brucei rhodiense具有显着的活性。 化合物A2和化合物A3,具有含卤素芳基的双环碳水化合物,对引起利什曼病的寄生虫的利什曼原虫(Leishmania donovani)具有显着的活性。 一般来说,双环碳水化合物,化合物A1,化合物A2和化合物A3更具体地可能是今后睡眠病和利什曼病的治疗方法。